FDA Inspection 1265571 — Gabor Kovacs, M.D., Ph. D.
The FDA completed an inspection of Gabor Kovacs, M.D., Ph. D. on Mar 12, 2025 in Budapest. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 12, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Budapest (Hungary)
Additional details
Clinical Investigator (CI)